TP53 and malignant colon neoplasm: The current study was aimed to investigate the cytotoxic effects induced by the chemotherapeutic drug OX in wild-type TP53 harboring HCT 116 and mutant TP53 harboring HT 29 colon cancer cells as well as to elucidate the underlying molecular mechanisms in correlation to their p53 status.